CRA assessed whether disputed representations of bioequivalence significantly affected sales of the branded product. CRA’s evaluation included consideration of distribution channels, purchase timing, and the effect of payor control mechanisms on product uptake and sales. The case ultimately resulted in a settlement.
The economics and global implications of the French Google decision in ad tech
In this new episode of Antitrust Code by Concurrences, Mikaël Hervé explains the economics and global implications of the French Google decision in ad...